Free Access
Reprod. Nutr. Dev.
Volume 45, Number 6, November-December 2005
Page(s) 709 - 720
References of Reprod. Nutr. Dev. 45 709-720
  1. Maggiolini M, Carpino A, Bonofiglio D, Pezzi V, Rago V, Marsico S, Picard D, Ando S. The direct proliferative stimulus of dehydroepiandrosterone on MCF7 breast cancer cells is potentiated by overexpression of aromatase. Mol Cell Endocrinol 2001, 184: 163-171 [CrossRef] [PubMed].
  2. Sasano H, Harada N. Intratumoral aromatase in human breast, endometrial, and ovarian malignancies. Endocr Rev 1998, 19: 593-607 [CrossRef] [PubMed].
  3. Noble LS, Simpson ER, Johns A, Bulun SE. Aromatase expression in endometriosis. J Clin Endocrinol Metab 1996, 81: 174-179 [CrossRef] [PubMed].
  4. Kitawaki J, Noguchi T, Amatsu T, Maeda K, Tsukamoto K, Yamamoto T, Fushiki S, Osawa Y, Honjo H. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod 1997, 57: 514-519 [CrossRef] [PubMed].
  5. Kitawaki J, Kusuki I, Koshiba H, Tsukamoto K, Fushiki S, Honjo H. Detection of aromatase cytochrome P-450 in endometrial biopsy specimens as a diagnostic test for endometriosis. Fertil Steril 1999, 72: 1100-1106 [CrossRef] [PubMed].
  6. Takayama K, Zeitoun K, Gunby RT, Sasano H, Carr BR, Bulun SE. Treatment of severe post menopausal endometriosis with an aromatase inhibitor. Fertil Steril 1998, 69: 709-713 [CrossRef] [PubMed].
  7. Dizerega GS, Barber DL, Hodgen GD. Endometriosis: role of ovarian steroids in initiation, maintenance, and suppression. Fertil Steril 1980, 33: 649-653 [PubMed].
  8. Kitawaki J, Kado N, Ishihara H, Koshiba H, Kitaoka Y, Honjo H. Endometriosis: the pathophysiology as an estrogen-dependent disease. J Steroid Biochem Mol Biol 2003, 83: 149-155.
  9. Rice VA. Conventional medical therapies for endometriosis. Ann N Y Acad Sci 2002, 955: 343-352 [PubMed].
  10. Ajossa S, Mais V, Guerrierero S, Paoletti AM, Caffiero A, Murgia C, Melis GB. The prevalence of endometriosis in premenopausal women undergoing gynecological surgery. Clin Exp Obstet Gynecol 1994, 21: 195-197 [PubMed].
  11. Hilakivi-Clarke L, Cho E, De Assis S, Olivo S, Ealley E, Bouker KB, Welch JN, Kan G, Clarke R, Cabanes A. Maternal and prepubertal diet, mammary development and breast cancer risk. J Nutr 2001, 131: 154S-157S [PubMed].
  12. Katadre M, Osborne M, Telang NT. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells. Int J Oncol 2002, 21: 809-815 [PubMed].
  13. Hale G, Bievre M, Hughes C. Exploring the role of progestins and phytoestrogens in menopause. Integr Med. 1999, 2: 133-141.
  14. Vincent A, Fitzpatrick LA. Soy isoflavones: are they useful in menopause? Mayo Clin Proc 2000, 75: 1174-1184 [PubMed].
  15. Campbell DR, Kurzer MS. Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J Steroid Biochem Mol Biol 1993, 46: 381-388 [CrossRef] [PubMed].
  16. Adlercreutz H, Bannwart C, Wahala K, Makela T, Brunow G, Hase T, Arosemena PJ, Kellis Jr. JT, Vickery LE. Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 1993, 44: 147-153 [CrossRef] [PubMed].
  17. Celec P, Ostatnikova D, Caganova M, Zuchova S, Hodosy J, Putz Z, Bernadic M, Kudela M. Endocrine and cognitive effects of short-time soybean consumption in women. Gynecol Obstet Invest 2004, 59: 62-66 [PubMed].
  18. Tham DM, Gardner CD, Haskell WL. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 1998, 83: 2223-2235 [CrossRef] [PubMed].
  19. Kao Y, Zhou C, Sherman M, Laughton CA, Chen S. Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavones phytoestrogens: a site-directed mutagenesis study. Environ Health Perspect 1998, 106: 85-92.
  20. Jeong HJ, Shin YG, Kim IH, Pezzuto JM. Inhibition of aromatase activity by flavonoids. Arch Pharm Res 1999, 22: 309-312 [PubMed].
  21. Simpson ER, Zhao Y, Agarwal VR, Michael MD, Bulun SE, Hinshelwood MM, Graham-Lorence S, Sun T, Fisher CR, Qin K, Mendelson CR. Aromatase Expression in Health and Disease. Recent Prog Horm Res 1997, 52: 185-213 [PubMed].
  22. Stresser DM, Turner SD, McNamara J, Stocker P, Miller VP, Crespi CL, Patten CJ. A high-throughput screen to identify inhibitors of aromatase (CYP19). Anal Biochem 2000, 284: 427-430 [CrossRef] [PubMed].
  23. Cheng Y, Prusoff WH. Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 1973, 22: 3099-3108 [CrossRef] [PubMed].
  24. Arnold JT, Kaufman DG, Seppälä M, Lessey BA. Endometrial stromal cells regulate epithelial cell growth in vitro: a new co-culture model. Hum Reprod 2001, 16: 836-845 [CrossRef] [PubMed].
  25. Garzo VG, Dorrington JH. Aromatase activity in human granulosa cells during follicular development and the modulation by follicle-stimulating hormone and insulin. Am J Obstet Gynecol 1984, 148: 657-662 [PubMed].
  26. Brodie AM, Shwarzel WC, Shaikh AA, Brodie HJ. The effect of an aromatase inhibitor, 4-hydroxy-4-androstene-3,17-dione, on estrogen-dependent processes in reproduction and breast cancer. Endocrinology 1977, 100: 1684-1695 [PubMed].
  27. Valentin-Blasini L, Blount BC, Caudill SP, Needham LL. Urinary and serum concentrations of seven phytoestrogens in a human reference population subset. J Exp Anal Environ Epidemiol 2003, 13: 276-282.
  28. Fanti P, Stephenson TJ, Kaariainen IM, Rezkalla B, Tsukamoto Y, Morishita T, Nomura M, Kitiyakara C, Custer LJ, Franke AA. Serum isoflavones and soya food intake in Japanese, Thai and American end-stage renal disease patients on chronic haemodialysis. Nephrol Dial Transplant 2003, 18: 1862-1868 [PubMed].
  29. Grace PB, Taylor JI, Botting NP, Fryatt T, Oldfield MF, Al-Maharik N, Bingham SA. Quantification of isoflavones and lignans in serum using isotope dilution liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom 2003, 17: 1350-1357 [CrossRef] [PubMed].
  30. Taga S, Yoshida N, Sekiba K. Distribution and cyclic change of aromatase cytochrome P-450 activity in human uteri. J Steroid Biochem Mol Biol 1990, 37: 741-745 [CrossRef] [PubMed].
  31. Sanderson JT, Seinen W, Giesy JP, van den Berg M. 2-chloro-s-triazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells: A novel mechanism for estrogenicity. Toxicol Sci 2000, 54: 121-127 [CrossRef] [PubMed].
  32. Sanderson JT, Boerma J, Lansbergen GW, den Berg M. Induction and inhibition of aromatase (CYP19) activity by various classes of pesticides in H295R human adrenocortical carcinoma cells. Toxicol Appl Pharmacol 2002, 182: 44-54 [CrossRef] [PubMed].
  33. Sanderson JT, Hordijk J, Denison MS, Springsteel MF, Nantz MH, van den Berg M. Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells. Toxicol Sci 2004, 82: 70-79 [CrossRef] [PubMed].
  34. Kayisli UA, Aksu CAH, Berkkanoglu M, Arici A. Estrogenicity of isoflavones on human endometrial stromal and glandular cells. J Clin Endocrinol Metab 2002, 87: 5539-5544 [CrossRef] [PubMed].
  35. Foth D, Cline JM. Effects of mammalian and plant estrogens on mammary glands and uteri of macaques. Am J Clin Nutr 1998, 68: 1413S-1417S [PubMed].
  36. Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S, Di Renzo GC. Endometrial effects of long-term treatment with phytoestrogens a randomized, double-blind, placebo-controlled study. Fertil Steril 2004, 82: 145-148 [CrossRef] [PubMed].
  37. Unfer V, Casini ML, Costabile L, Mignosa M, Gerli S, Di Renzo GC. High dose of phytoestrogens can reverse the antiestrogenic effects of clomiphene citrate on the endometrium in patients undergoing intrauterine insemination: A randomized trial. J Soc Gynecol Investig 2004, 11: 322-328.
  38. Bulun SE, Yang S, Fang Z, Gurates B, Tamura M, Sebastian S. Estrogen production and metabolism in endometriosis. Ann N Y Acad Sci 2002, 955: 75-85 [PubMed].
  39. Santell RC, Chang YC, Nair MG, Helferich WG. Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J Nutr 1997, 127: 263-269 [PubMed].
  40. Diel P, Smolnikar K, Schulz T, Laudenbach-Leschowski U, Michna H, Vollmer G. Phytoestrogens and carcinogenesis-differential effects of genistein in experimental models of normal and malignant rat endometrium. Hum Reprod 2001, 16: 997-1006 [CrossRef] [PubMed].
  41. Weihua Z, Saji S, Makinen S, Cheng G, Jenson EV, Warner M, Gustafsson J. Estrogen receptor (ER) $\beta$, a modulator of ER$\alpha$ in the uterus. PNAS 2000, 97: 5936-5941 [CrossRef].
  42. Kuppusamy UR, Das NP. Effects of flavonoids on cyclic AMP phosphodiesterase and lipid mobilization in rat adipocytes. Biochem Pharmacol 1992, 44: 1307-1315 [CrossRef] [PubMed].
  43. Nichols MR, Morimoto BH. Tyrosine kinase-independent inhibition of cyclic-AMP phosphodiesterase by genistein and tyrphostin 51. Arch Biochem Biophys 1999, 366: 224-230 [CrossRef] [PubMed].
  44. Burvall KM, Palmberg L, Larsson K. The tyrosine kinase inhibitor genistein increases basal cAMP and potentiates forskolin-induced cAMP accumulation in A549 human airway epithelial cells. Mol Cell Biochem 2002, 240: 131-133 [CrossRef] [PubMed].
  45. Sofi M, Young MJ, Papamakarios T, Simpson ER, Clyne CD. Role of CRE-binding protein (CREB) in aromatase expression in breast adipose. Breast Cancer Res Treat 2003, 79: 399-407 [CrossRef] [PubMed].
  46. Noble LS, Takayama K, Zeitoun KM, Putman JM, Johns DA, Hinshelwood MM, Agarwal VR, Zhao Y, Carr BR, Bulun SE. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab 1997, 82: 600-606 [CrossRef] [PubMed].
  47. Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT, Kirschner AS, Cassidy A, Heubi JE. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements. J Nutr 2001, 131 (Suppl): 1362S-1375S.
  48. Ross JA, Kasum CM. Dietary flavonoids: bioavailability, metabolic effects, and safety. Annu Rev Nutr 2002, 22: 19-34 [CrossRef] [PubMed].
  49. Goodman MT, Wilkens LR, Hankin JH, Lyu LC, Wu AH, Kolonel LN. Association of soy and fiber consumption with the risk of endometrial cancer. Am J Epidemiol 1997, 146: 294-306 [PubMed].
  50. Guthrie JR, Ball M, Murkies A, Dennerstein L. Dietary phytoestrogen intake in mid-life Australian-born women: relationship to health variables. Climacteric 2000, 3: 254-261 [PubMed].
  51. Miyazawa K. Incidence of endometriosis among Japanese women. Obstet Gynecol 1976, 48: 407-409 [PubMed].
  52. Arumugam K, Templeton AA. Endometriosis and race. Aust N Z J Obstet Gynaecol 1992, 32: 164-165 [PubMed].